Article detail · 2026
Esculetin attenuates doxorubicin-induced cardiac toxicity: Evidence from gene expression, enzyme activity, and molecular docking analyses
YÖKSİS
OpenAlex
SJR Q2
JCR Q1
Citations 32
Top 1%
Percentile 99.6%
FWCI 21.67
- Year
- 2026
- Type
- article
Data source split
- YÖKSİS YÖKSİS article record
- YÖKSİS venue Computational Biology and Chemistry
- Catalog match (ISSN) Computational Biology and Chemistry
- OpenAlex OpenAlex enrichment (abstract, citations, topics)
Abstract
Abstract not compiled yet; it will appear after the DergiPark / OpenAlex queue runs.
Topics
Citations
OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.
32 citations
OpenAlex cited_by_count (cache / database)
22 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).
- Esculetin Attenuates Doxorubicin‐Induced Cardiotoxicity via Modulation of Apoptotic and Mitochondrial Gene Expression Networks 2025
- Esculetin Attenuates Doxorubicin-Induced Cardiotoxicity via Modulation of Apoptotic and Mitochondrial Gene Expression Networks 2025
- Esculetin Attenuates Doxorubicin‐Induced Cardiotoxicity via Modulation of Apoptotic and Mitochondrial Gene Expression Networks 2025
- Esculetin Attenuates Doxorubicin‐Induced Cardiotoxicity via Modulation of Apoptotic and Mitochondrial Gene Expression Networks 2025
- Esculetin Attenuates Doxorubicin‐Induced Cardiotoxicity via Modulation of Apoptotic and Mitochondrial Gene Expression Networks 2025
- Systems-level integration of machine learning, SHAP explainability, PCA, and network topology reveals multitarget protective actions of tannic acid against doxorubicin toxicity in pentose phosphate pathway 2026
- Novel Approach to Synthesis of Diaryl Tacrine Derivatives and Evaluation of Their Inhibitory Effects on Cholinesterase Enzymes 2026
- Novel Approach to Synthesis of Diaryl Tacrine Derivatives and Evaluation of Their Inhibitory Effects on Cholinesterase Enzymes 2026
- Design, Synthesis, and Biological Evaluation of Biphenylsulfonyl Indole‐Based Thiosemicarbazones as Potential AChE and CA I‐II Inhibitors 2026
- Design, Synthesis, and Biological Evaluation of Biphenylsulfonyl Indole‐Based Thiosemicarbazones as Potential AChE and CA I‐II Inhibitors 2026